Baranova, M. M., Muravyeva, N. V., Belov, B. S., Diatroptov, M. E., & Bukhanova, D. V. (2024). Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy. LLC "Publishing House OKI".
Citación estilo ChicagoBaranova, M. M., N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, and D. V. Bukhanova. Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy. LLC "Publishing House OKI", 2024.
Cita MLABaranova, M. M., et al. Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy. LLC "Publishing House OKI", 2024.